Barkan, D. et al. Inhibition of metastatic outgrowth from single dormant tumor cells by targeting the cytoskeleton. Cancer Res. 68, 6241–6250 (2008).
Barkan, D. et al. Metastatic growth from dormant cells induced by a col-I-enriched fibrotic environment. Cancer Res. 70, 5706–5716 (2010).
Barkan, D., Green, J. E. & Chambers, A. F. Extracellular matrix: a gatekeeper in the transition from dormancy to metastatic growth. Eur. J. Cancer 46, 1181–1188 (2010).
El Touny, L. H. et al. Combined SFK/MEK inhibition prevents metastatic outgrowth of dormant tumor cells. J. Clin. Invest. 124, 156–168 (2014).
Shibue, T. & Weinberg, R. A. Integrin beta1-focal adhesion kinase signaling directs the proliferation of metastatic cancer cells disseminated in the lungs. Proc. Natl Acad. Sci. USA 106, 10290–10295 (2009).
Shibue, T., Brooks, M. W. & Weinberg, R. A. An integrin-linked machinery of cytoskeletal regulation that enables experimental tumor initiation and metastatic colonization. Cancer Cell. 24, 481–498 (2013).
Shibue, T., Brooks, M. W., Inan, M. F., Reinhardt, F. & Weinberg, R. A. The outgrowth of micrometastases is enabled by the formation of filopodium-like protrusions. Cancer Discov. 2, 706–721 (2012).
Ding, Z., Bae, Y. H. & Roy, P. Molecular insights on context-specific role of profilin-1 in cell. Migr. Cell Adhes. Migr. 6, 442–449 (2012).
Janke, J. et al. Suppression of tumorigenicity in breast cancer cells by the microfilament protein profilin 1. J. Exp. Med. 191, 1675–1686 (2000).
Ding, Z. et al. Profilin-1 downregulation has contrasting effects on early vs late steps of breast cancer metastasis. Oncogene 33, 2065–2074 (2014).
Mouneimne, G. et al. Differential remodeling of actin cytoskeleton architecture by profilin isoforms leads to distinct effects on cell migration and invasion. Cancer Cell 22, 615–630 (2012).
Zou, L., Ding, Z. & Roy, P. Profilin-1 overexpression inhibits proliferation of MDA-MB-231 breast cancer cells partly through p27kip1 upregulation. J. Cell Physiol. 223, 623–629 (2010).
Bae, Y. H. et al. Loss of profilin-1 expression enhances breast cancer cell motility by Ena/VASP proteins. J. Cell Physiol. 219, 354–364 (2009).
Tang, Y. N. et al. Epigenetic regulation of Smad2 and Smad3 by profilin-2 promotes lung cancer growth and metastasis. Nat. Commun. 6, 8230 (2015).
Barkan, D., Green, J. E. An in vitro system to study tumor dormancy and the switch to metastatic growth. J. Vis. Exp. (2011).
Zou, L. et al. Profilin-1 is a negative regulator of mammary carcinoma aggressiveness. Br. J. Cancer 97, 1361–1371 (2007).
Joy, M., Gau, D., Castellucci, N., Prywes, R. & Roy, P. The myocardin-related transcription factor MKL co-regulates the cellular levels of two profilin isoforms. J. Biol. Chem. 292, 11777–11791 (2017).
Zerkowski, M. P., Camp, R. L., Burtness, B. A., Rimm, D. L. & Chung, G. G. Quantitative analysis of breast cancer tissue microarrays shows high cox-2 expression is associated with poor outcome. Cancer Invest. 25, 19–26 (2007).
Giltnane, J. M., Moeder, C. B., Camp, R. L. & Rimm, D. L. Quantitative multiplexed analysis of ErbB family coexpression for primary breast cancer prognosis in a large retrospective cohort. Cancer 115, 2400–2409 (2009).
Gau, D. M. et al. BRCA1 deficiency in ovarian cancer is associated with alteration in expression of several key regulators of cell motility - A proteomics study. Cell Cycle 14, 1884–1892 (2015).
Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545–15550 (2005).
Liberzon, A. et al. The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst. 1, 417–425 (2015).
Merico, D., Isserlin, R., Stueker, O., Emili, A. & Bader, G. D. Enrichment map: a network-based method for gene-set enrichment visualization and interpretation. PLoS ONE 5, e13984 (2010).
Gyorffy, B. et al. An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients. Breast Cancer Res. Treat. 123, 725–731 (2010).
Buchwalter, G. et al. PDEF promotes luminal differentiation and acts as a survival factor for ER-positive breast cancer cells. Cancer Cell 23, 753–767 (2013).
McCauley, H. A. et al. TGFbeta signaling inhibits goblet cell differentiation via SPDEF in conjunctival epithelium. Development 141, 4628–4639 (2014).
Kim, W. et al. The integrin-coupled signaling adaptor p130Cas suppresses Smad3 function in transforming growth factor-beta signaling. Mol. Biol. Cell 19, 2135–2146 (2008).
Fife, R. S. & Sledge, G. W. Jr. Effects of doxycycline on in vitro growth, migration, and gelatinase activity of breast carcinoma cells. J. Lab. Clin. Med. 125, 407–411 (1995).
Fife, R. S., Sledge, G. W. Jr, Roth, B. J. & Proctor, C. Effects of doxycycline on human prostate cancer cells in vitro. Cancer Lett. 127, 37–41 (1998).
Onoda, T. et al. Doxycycline inhibits cell proliferation and invasive potential: combination therapy with cyclooxygenase-2 inhibitor in human colorectal cancer cells. J. Lab. Clin. Med. 143, 207–216 (2004).
Li, Q. et al. Mucin1 shifts Smad3 signaling from the tumor-suppressive pSmad3C/p21(WAF1) pathway to the oncogenic pSmad3L/c-Myc pathway by activating JNK in human hepatocellular carcinoma cells. Oncotarget 6, 4253–4265 (2015).
Hayashida, T., Decaestecker, M. & Schnaper, H. W. Cross-talk between ERK MAP kinase and Smad signaling pathways enhances TGF-beta-dependent responses in human mesangial cells. FASEB J. 17, 1576–1578 (2003).
Sun, J. et al. Fascin protein is critical for transforming growth factor beta protein-induced invasion and filopodia formation in spindle-shaped tumor cells. J. Biol. Chem. 286, 38865–38875 (2011).
Li, L. et al. TGF-beta induces fascin expression in gastric cancer via phosphorylation of smad3 linker area. Am. J. Cancer Res. 5, 1890–1896 (2015).
Bae, Y. H. et al. Profilin1 regulates PI(3,4)P2 and lamellipodin accumulation at the leading edge thus influencing motility of MDA-MB-231 cells. Proc. Natl Acad. Sci. USA 107, 21547–21552 (2010).
Das, T., Bae, Y. H., Wells, A. & Roy, P. Profilin-1 overexpression upregulates PTEN and suppresses AKT activation in breast cancer cells. J. Cell Physiol. 218, 436–443 (2009).
Ebata, T. et al. Substrate stiffness influences doxorubicin-induced p53 activation via ROCK2 expression. Biomed. Res. Int. 2017, 5158961 (2017).